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SUMMARY 
A cDNA encoding rat plasminogen activator-inhibitor (PAL1) has been isolated from an HTC rat hepatoma 
cell cDNA library constructed in phage &tlO. The cDNA contains 118 bp of 5’untranslated sequence, 
1206 bp encoding a 402~amino acid (aa) protein and 1747 bp of 3’-untranslated sequence. The protein-coding 
sequence and the derived amino acid sequence share 82% and 81% identity, respectively, with human PAI- 
cDNA and protein. The rat cDNA encodes a preprotein with a 23-aa leader peptide and a predicted N-terminal 
serine for the mature protein. Three of four potential ~-~ycosylation acceptor sites as well as the active site 
of rat PA&l are identical to the human protein. The 3’-~~~slat~ region contains a number of unusual 
regions, includmg 80 bp of tandemly repeated G,A dinucleotides, a 11 S-bp stretch which shares greater than 
90% sequence identity with a region within the 3’-untranslated cDNA of human PAI-1, and two 70-bp 
stretches of highly T-rich sequence located close to the 3’-terminus of the cDNA. 
INTRODUCTION 
Plasminogen activator-inhibitors (PAIs) are key 
regulatory proteins in those physiolo~c~ and patho- 
logical processes which involve plasminogen activa- 
tor (PA)-catalyzed conversion of plasminogen to 
plasmin. These processes include fibrinolysis, ovu- 
lation, blastocyst implantation, macrophage migra- 
tion during inflammation and tissue remodeling 
(Verstraete and Collen, 1986; Canipari and 
Strickland, 1985; Strickland et al., 1976; Vassalli 
et al., 1976; Allen et al.., 1986; Dano et al., 1985). 
Plas~ogen activation has also been ~p~cat~ in 
tumor invasion and metastasis (Dano et al., 1985). 
Two types of PAIs, designated PAI-1 and PAI-2, 
appear to be the major physiological inhibitors of PA 
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activity in vivo, and can be distinguished on the 
basis of biochemical, immunological and molecular 
biological properties. 
PAI- 1 is encoded by a single-copy gene on human 
chromosome No. 7 (Ginsburg et al., 1986). It is the 
major PA-inhibitor found in the blood, and has been 
isolated from human endothelial cells (Philips et al., 
1984), platelets (Erickson et al., 1984), plasma 
(Kruithof et al., 1984), and fibrosarcoma cells 
(Andreasen et al., 1987), and from rat hepatoma 
cells (Zeheb et al., 1987) and a number of other 
cultured cell lines (Dano et al., 1985). PAI- is a 
glycoprotein of approximately 50 kDa which rapidly 
inhibits both tissue-type plasminogen activator 
(t-PA) and urokinase (uPA), and whose activity is 
acid- and denaturant-stable (Zeheb et al., 1987). 
PAI- activity can be regulated by a variety of hor- 
mones and other effecters including glucocorticoids 
(Gelehrter et al., 1983, 1987), thrombin (Gelehrter 
and Sznycer-Laszuk, 1986), bacterial endotoxins, 
IL-l and tumor necrosis factor (Sprengers and 
Kluft, 1987; Schleef et al., 1988), transforming 
growth factor-beta (Lund et al., 1987), and cyclic 
nucleotides (Barouski-Miller and Gelehrter, 1982; 
J.H. Heaton and T.D.G., unpublished). Abnormal 
expression of PAI- has been associated with 
cardiovascular disease, thromboembolic disease, 
and liver disorders in man (Sprengers and Kluft, 
1987; Kruithof et al., 1988). Recently, the nucleotide 
sequences of the human PAI-1 cDNA (Ginsburg 
et al., 1986; Ny et al., 1986; Pannekoek et al., 1986; 
Wun and Kretzmer, 1987) and gene (Bosma et al., 
1988; Loskutoff et al., 1987) have been published. 
PAI- is encoded on human chromosome No. 18 
(Webb et al., 1987). It occurs in both a glycosylated 
(60 kDa) and nonglycosylated (47 kDa) form and 
has been found in placenta and cells of the monocyte 
line (Sprengers and Kluft, 1987; Astedt et al., 1985; 
Wun and Reich, 1987). Serum levels of PAI- 
increase markedly during pregnancy (Kruithof et al., 
1987). The cDNA for human PAI- has been 
sequenced (Ye et al., 1987; Schleuning et al., 1987; 
Antalis et al., 1988). 
We have previously demonstrated that HTC rat 
hepatoma cells synthesize and secrete PAI- 
(Coleman et al., 1982; Cwikel et al,, 1984; Coleman 
et al., 1986). Incubation of HTC cells with the 
synthetic glucocorticoid dexamethasone induces a 
rapid, five to ten-fold increase of PAI- activity, 
protein and mRNA (Coleman et al., 1982; Cwikel 
et al., 1984; Gelehrter et al., 1987; J.H. Heaton and 
T.D.G. unpublished). In order to investigate the 
structural and functional properties of rat PA&l, its 
relationship with other serine protease inhibitors 
(set-pins) and its mode of regulation, we have cloned 
and sequenced the cDNA encoding HTC rat 
hepatoma cell PAI- 1. 
MATERIALS AND METHODS 
(a) cDNA library construction 
A cDNA library was constructed in the bacterio- 
phage vector &tlO using mRNA extracted from 
HTC rat hepatoma cells which had been incubated 
for 16 h in the presence of 1 PM dexamethasone 
(Sigma Chemical Co.). Total RNA was isolated 
from approximately 5 x lo8 cells using a modified 
guanidine HCl procedure (Strohrnan et al., 1977), 
and the poly(A) + RNA purified by afTimity chromato- 
graphy using oligo(dT)-cellulose (Pharmacia Inc.) 
(Maniatis et al., 1982). cDNA was synthesized using 
oligo(dT>primers and reverse transcriptase utilizing 
a cDNA synthesis kit (Amersham Corp.). The 
cDNA was methylated to protect internal EcoRI 
sites, then ligated to EcoRI linkers according to the 
instructions provided by the manufacturer. The 
ligated DNA was annealed to phage @lo arms and 
the resultant concatamers were packaged, in vitro, 
using Gigapack Gold (Stratagene) packaging 
extracts. The complete recombinant phage were then 
used to infect E. coli strains L87 (nonselective host) 
and NM5 14 (Hfl + , selective host), supplied with the 
kit. The library was characterized on both bacterial 
strains; subsequent plating and screening was per- 
formed using only the selective host. 
(b) Screening of cDNA library 
The unamplified HTC cDNA library, plated onto 
the selective bacterial host NM5 14, was screened by 
standard plaque hybridization techniques (Maniatis 
et al., 1982) utilizing the previously cloned human 
PAI- cDNA as a probe (Ginsburg et al., 1986). The 
probe was radiolabeled using the random primer 
method (Feinberg and Vogelstein, 1983) and used to 
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screen duplicate filters under stringent conditions 
(40% formamide, 5 x SSPE at 42” C). Filters were 
washed to a final stringency of 0.5 x SSC, 42°C and 
positive phage were plaque-puritied. 
(c) Characterization of cloned inserts 
Plaque-purified phage were grown as minipreps, 
and phage DNA isolated as described (Maniatis 
et al., 1982). The purified DNA was digested with 
EcoRI (Boehringer-Mannheim) in order to release 
the cloned inserts, and analysed on 1% agarose 
(BRL) gels using TBE (Sigma, Fisher) as the elec- 
trode buffer (Maniatis et al., 1982). After staining 
with ethidium bromide (Sigma), bands were visual- 
ized under UV irradiation (Transilluminator, UVP 
Inc.) and the size of the cDNA inserts determined 
relative to size standards (HindIII- or BstEII- 
digested I DNA, New England Biolabs, Inc.). Insert 
DNA was subcloned into the EcoRI sites of the 
multifunctional plasmid vectors pBSM13( - ) and 
pBluescript SK( - ) and used to transfect competent 
host E. coli strain AG-1 (Stratagene, Inc., La Jolla, 
CA). Plasmids were grown as minipreps and DNA 
was isolated and used to construct restriction maps. 
(d) Nucleotide sequence analysis 
Sequencing of cloned DNA inserts was facilitated 
by construction of nested deletions using exonucle- 
ase III/mung bean nuclease digestion, according to 
the procedure described by Stratagene. For con- 
struction of the nested deletions, DNA was isolated 
from large-scale preparations and purified by CsCl 
(Boehringer-Mannheim) banding (Maniatis et al., 
1982). Sequence analysis was performed directly 
from double-stranded plasmid DNA according 
to the method of Sanger et al. (1977), as modi- 
fied by Hattori and Sakaki (1986), and using 
deoxyadenosine 5’-[a-35S]thiotriphosphate (Amer- 
sham). Both the coding and noncoding strands were 
sequenced and the data analysed with the IBI-Pustell 
sequence analysis programs (International Biotech- 
nologies, Inc.) (Pustell and Kafatos, 1986), and with 
the Sequence Analysis Software Package (version 5) 
of the Genetics Computer Group at the University 
of Wisconsin (Devereux et al., 1984). 
(e) Ceil cultures 
HTC rat hepatoma cells were cultured as previ- 
ously described and the PAI- 1 activity in the medium 
of the cultured cells was determined by a two-step 
esterolytic assay (Gelehrter et al., 1987). 
RESULTS AND DISCUSSION 
(a) Characterization and screening of the HTC 
cDNA library 
By titering the HTC cDNA library on both the 
nonselective (L87) and selective (NM514) bacterial 
hosts, the library was characterized with respect to 
background (3.7 x lo3 pfu/ml), number of recombi- 
nants (5.1 x lo4 pfu/ml), percent recombinants 
(93 %) and cloning efficiency (approximately 
1 x lo6 pfu/pg of DNA). In addition, purification of 
phage DNA from 18 randomly selected clones 
revealed that 17 of the 18 (94%) contained insert 
DNA ranging in size from approximately 400 bp to 
greater than 3.5 kb and averaging 2 kb. 
The library (6 x lo4 plaques) was screened using 
the 2-kb human PAI- cDNA (PAIB6) as a probe 
(Ginsburg et al., 1986). This probe does not contain 
either a poly(A) tail or the partial Alu repeated 
sequence which is present in the 3’-untranslated 
region of the 3-kb human PAI- cDNA (PAIB4). On 
primary screening, the probe hybridized to 26 
plaques, 24 of which remained positive through 
secondary and tertiary rounds of plaque-purification 
and rescreening. These results suggest that the 
abundance of the message is approximately 1: 2000 
in the library. Studies from this laboratory (J.H. 
Heaton and T.D.G., unpublished) have shown that 
dexamethasone causes approximately a five-fold 
increase in the steady-state accumulation of PAI- 
mRNA; therefore, the abundance of PAI- mRNA 
in untreated HTC cells is approximately 0.01% of 
the total poly(A) + RNA. 
Phage DNA was purified from the positive clones 
and the size of the insert DNA determined. One 
clone, harboring an insert of approximately 3 kb, was 
selected for further analysis based on the close cor- 
respondence of its size to that of HTC PAI- 
mRNA, determined by Northern blot analysis of 
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PARTIAL RESfRlCflON MAP OF HTC RAT PAI- cDNA 
SO? bp 1WObP 15OObP 2000 bp 2500 bp 3000 bp 
Fig. 1. Partial restriction map ofrat PAI- cDNA. The map was 
constructed by digesting purified plasmid pBSM13( - ), contain- 
ing the PAI- cDNA insert, with the indicated restriction endo- 
nucleases singly and in combination. Digestion fragments were 
analysed by electrophoresis in 1% agarose gels, stained with 
ethidium bromide and visualized under UV irradiation. The 
cDNA clone is oriented 5’ to 3’ with respect to the coding strand. 
B, &$I; H, HltldIII; P, &I; Pv, PVUII. 
total HTC cell RNA probed with the human PAIB6 
cDNA (J.H. Heaton and T.D.G., unpublished). The 
insert DNA was subcloned into pBSM13( - ) and 
into pBluescript SK( - ) and a partial restriction map 
determined (Fig. 1). The presence of unique PstI and 
Hind111 sites at the 5’- and 3’-ends of the insert, 
respectively, were used to orient the clone. 
(b) Nuckotide sequence determination 
Nested deletions of the subcloned DNA, over- 
lapping by 150-300 bp, were constructed and both 
strands sequenced as described in MATERIALS AND 
METHODS, section d. The nucleotide sequence of the 
cDNA encoding rat PAI-1 is shown in Fig. 2. The 
HTC PAL1 cDNA is 3071 bp in length and consists 
of 118 bp of 5’untranslated sequence with an 
in-frame stop codon at position -51, 1206 bp en- 
coding a 402-aa protein, and 1747 bp of 3’-untrans- 
lated sequence terminating in a poly(A) tail. Com- 
parison of the nucleotide sequence of the rat PAI-1 
cDNA with the pre~ously characterized human 
PAI- cDNA (Ginsburg et al., 1986; Ny et al., 1986; 
Pannekoek et al., 1986; Wun and Kretzmer, 1987) 
shows that these three regions share 57 %, 82%) and 
59% sequence identity, respectively. The cDNAs are 
68 % identical, overall. 
(c) Analysis of the 5’4mtranslated region 
The rat PAI-1 cDNA has 118 bp of 5’~untraus- 
lated sequence and is estimated to be missing 
25-35 nt from the 5’-end. This estimate is suppled 
by a comparison of the sequence and organization of 
the rat and human (Bosma et al., 1988) PAI-1 genes. 
Analysis of the rat PAI- gene (C.J. Bruzdzinski and 
T.D.G., unpublished) has identified a TATA box 
starting 174 nt upstream of the ~~slation~ start 
codon. In addition, there is an ~~on/exon boundary 
at position -1 from the translation-start codon. The 
human gene has a TATA box which starts at position 
-173, and the boundary between exons 1 and 2 
occurs at position -1. The high degree of similarity 
in the organization of these two genes suggests that 
the transcriptional start point of human PAL1 (posi- 
tion -145) and that of the rat message may be similar. 
Finally, a full-length rat PAI- mRNA, starting at 
position -145, would result in a 29-bp distance 
between the TATA box and the ~~sc~ption~ start 
point; a number which is in close a~~rnent with the 
30-bp distance generally observed in other 
eukaryotic genes (Bucher and Ttionov, 1986). 
(d) Analysis of the protein-coding region 
The rat PAI-1 protein shares considerable se- 
quence similarity with other members of the serine 
protease inhibitor family (Table I). The rat PAI-1 
cDNA encodes a preprotein with a 23-aa hydro- 
phobic leader peptide, the cleavage of which results 
in a 379-aa mature protein having an N-terminal 
serine residue (Fig. 3). This is consistent with pri- 
mary amino acid sequence data obtained on a 
sample of puriIied HTC PAI-1 protein (data not 
shown). The N-terminal regions of rat and human 
PAI- show the greatest extent of sequence diver- 
gence. Ten out of the first 14 aa of the mature rat 
protein differ from those of human PA&l, whereas 
overall they share 81% sequence identity (89% 
sequence similarity). Divergence of the N-terminal 
region is a feature of other serpins and may represent 
an area where specific functional ditYerences occur, 
or a relatively nonessential area which is able to 
tolerate a high frequency of amino acid substitutions 
without compromising the function of the protein. 
Since rat and human PAI-1 appear to function in the 
same way, it seems unlikely that the N-terminal 
sequence divergence reflects a functional difference 
between these two proteins. Four potential N-glyco- 
sylation acceptor sites are predicted (Fig. 3), 
three of which are identical to those predicted for 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Amino acid sequence sorties between rat PAI-1 and related 
proteins 
























a Belated proteins were identified by scanning the Genbank 
peptide file using the WordSearch program (Devereux et al., 
1984). Optimal alignment of rat PAI- to each related protein 
was determined using the Gap ahgmnent program with a match 
display threshold of 1.5. At this setting only exact matches are 
used in calculating the percent ammo acid sequence identity. 
’ Sequence similarity was determined as in a except that the 
match display threshold was set to 0.5, a setting which scores 
‘conservative’ amino acid changes as a match (Devereux et al., 
1984). 
glycosylation of the protein is not needed for activity 
(Zeheb et al., 1987). By homology to human PAI-1, 
the active site Pl and Pl ’ residues are predicted to 
be arginine 369 and methionine 370, respectively 
(n~~~g based on the 402~aa preprotein). The 
amino acids at the active site are identical to those 
ident~~ for the active site of human PA&l, and 
present an appropriate site for cleavage by arginine- 
specific serine proteases. 
The human PAI- amino acid sequence is more 
closely related to rat PAI- (8 1% sequence identity) 
than it is to human PAI- (30% sequence identity 
(Ginsburg et al., 1986)), suggesting that PAI- and 
PAI- diverged prior to the separation of these two 
species. 
(e) Analysis of the 3’-untranslated region 
The rat PAI- cDNA has a long 3 ‘-untranslated 
region (1747 bp) within which are located a number 
of unusual and interesting sequences. Unlike human 
PA&l, for which there are two size classes of 
message, only one size mRNA is found in Northern 
blots of rat HTC hepatoma cells (J-H. Heaton and 
T.D.G., manuscript in preparation) and normal 
hepatocytes (J.H. Heaton, V.L. Nebes, L.G. O’Dell, 
SM. Morris Jr. and T.D.G., Molecular Endo- 
crinology, submitted). The size of the mRNA 
(appro~ately 3 kb) corresponds well to the size of 
the cDNA. It has been suggested that the smaller 
human PAI- mRNA is formed by polyadenylation 
in response to a weak upstream poly(A) addition 
signal which does not match the consensus sequence. 
Candidate poly(A) addition sequences have been 
proposed including CCTAAA (located at position 
2000 bp of the cDNA), AAATAA (position 
2049 bp), TTTAAA (position 2060 bp), (Ginsburg 
et al., 1986) and AATAAT (position 11174 bp of the 
gene sequence, position 2050 bp of the cDNA) 
(Bosma et al., 1988). Polyadenylation in response to 
any of these signals could result in the formation of 
a smaller message whose size would correspond to 
the observed size (approximately 2 kb) of the smaller 
human mRNA. Comparison with the rat cDNA 
sequence reveals that there is one consensus poly(A) 
addition signal, AATAAA, located 18 bp 5’ to the 
start of the poly(A) tail, and that of the four possible 
alternative sites found in the human sequence, only 
one (TTTAAA) is preserved intact in the rat 
sequence. Since only one size message is formed in 
the rat, this would suggest that this site is not an 
alternative poly(A) addition signal. 
The 3’-untranslated region contains an 80-bp seg- 
ment of pol~~es organized in the form 
(GAX,A,(GA),. Tandem repeats of the dinucleotide 
G,A have been found within the introns of other 
genes including the murine immunoglobulm p-6. 
heavy-chains (Richards et al., 1983) and IgG3 con- 
stant region (Wels et al., 1984), a murine pro- 
opiomelanocortin pseudogene (Notake et al., t983; 
Uhler et al., 1983), and the 3’-end spacer of mouse 
ribosomal RNA genes (Kominami and Muramatsu, 
1983). In addition, another serpin, mouse a,-anti- 
trypsin, has a long G,A dinucleotide repeat approxi- 
mately 300 bp upstream from the start of tran- 
scription (Krauter et al., 1986). The rat PA&l cDNA 
appears to be the first example of such a nucleotide 
sequence appearing in the exon of a gene. As yet, no 
clear-cut function has been associated with any of 
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306 EVTXRGPLEXCWID IFs~E’r~SSTAILV 366 
lllll III IIIII I IIIIlllIIll I IIIIIIIIIIIIIIIIIIIIIIII I 
306 EW?I@?~ETS~IWGWWKI~~VIV 366 
367 ~RS~ILn;a- 402 
IIlllI I II llIIIIIlIl I Illll III 
367 WEEIIMXPP 402 
Fig. 3. Alignment of rat and human PAI- peptide sequences. Alignment was determined as described in footnote a to Table I. The 
amino acids are numbered beginning with the initiator methionine. Identical amino acids are connected by vertical lines. The downward 
arrow indicates the leader peptide cleavage site. Potential N-linked glycosylation acceptor sites are marked by asterisks. The active sites 
are enclosed by brackets. 
these sequences, though it has been proposed that 
they may serve as ‘hot spots’ for homologous recom- 
bination. The occurrence of such a sequence in the 
5 ’ ‘switch’ region of the murine immunoglobulin gene 
(Wels et al., 1984) has prompted speculation that it 
may be involved in class-switching, It is interesting 
to note that the human PAI- gene contains eleven 
sequences which are 77% to 90% identical to the 
consensus for the Alu repeated sequence; four of 
these are contiguous on their 3’-ends with long 
stretches of polypurine repeats which basically con- 
form to an organization of (GA,), (Bosma et al., 
1988). None of the human PAI- gene &u-like 
sequences or polypurine sequences occur within 
exons. 
Sixty bp 3’ to the end of the G,A dinucleotide 
repeat is a 115bp region which has greater than 90 y0 
sequence identity to a stretch of nucleotide sequence 
in the 3’ -untranslated region of human PAI- 
(Fig. 2). This extremely high degree of sequence 
identity is unusual in that it occurs in non-protein 
coding regions of the two cDNAs. The preservation 
of a high degree of nucleotide sequence similarity 
within the 3’-untranslated regions of mRNAs from 
different animal species has been reported for a num- 
ber of highly conserved proteins including actin 
(Ordahl and Cooper, 1983), tubulin (Cowan et al., 
1983), myosin (Saidapet et al., 1984) and the B sub- 
unit of creatine kinase (Billadello et al., 1986; 
Papenbrock and Wille, 1986). Recently, the cDNA 
encoding human multilineage-colony-stimulating 
factor was identified by hybridization with highly 
conserved regions in the 3’untranslated region of 
mouse IL-3 (Dorssers et al., 1987). Nucleotide 
sequence preservation within the 3’ -untranslated 
region implies a specific and essential function. As 
yet, the nature of that function is unknown. 
Finally, close to the 3’-end of the cDNA are two, 
approximately 70-bp stretches of highly T-rich se- 
quence, one of which is located in a position 
466 
analogous to the AT-rich region previously identified 
in the human PAI- cDNA (Ginsburg et al., 1986). 
Studies of message stability have shown that mRNA 
from some genes are degraded at a much faster rate 
than others (Ross and Kobs, 1986). The presence of 
AU-rich sequences in the 3’-untranslated regions, in 
particular the nucleotide sequence UUAUUUAU, 
may be associated with message lability (Shaw and 
Kamen, 1986). The highly T-rich regions of the rat 
PAI- cDNA may be examples of other sequences 
which may play a role in the regulation of mRNA 
stability. 
(f) Conclusions 
(1) A nearly full-length cDNA encoding rat PAI- 1 
from HTC cells has been cloned and sequenced. The 
cDNA is 307 1 bp in length and consists of 118 bp of 
5’-untranslated sequence, a 1206-bp open reading 
frame, and 1747 bp of 3’-untranslated sequence. The 
HTC PAI- cDNA shares 68% sequence identity 
with the cDNA encoding human endothelial cell 
PAI-1. 
(2) The cDNA encodes a 402-aa preprotein hav- 
ing a 23-aa leader peptide and four potential acceptor 
sites for N-linked glycosylation. The rat PAI-1 pro- 
tein shares considerable amino acid similarity with 
other members of the serine protease inhibitor 
family. Rat and human PAI- 1 share 8 1% amino acid 
sequence identity (89% sequence similarity). 
(3) The 3’-translated region of the cDNA 
contains a number of unusual regions which may be 
involved in the regulation of PAI- gene expression 
in HTC cells. These regions include 80 bp of (G,A)- 
repeated dinucleotide sequence; 115 bp which share 
greater than 90% sequence identity with a region 
within the 3’-untranslated cDNA of human PAI-1; 
and two 70-bp stretches of highly T-rich sequence 
located close to the 3’-terminus of the cDNA. 
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